Plasma Thrombomodulin Levels and Ischemic Stroke: A Population-Based Prognostic Cohort Study.
Zhengbao ZhuDaoxia GuoYiming JiaKaixin ZhangMengyao ShiYanbo PengPinni YangJing ChenJintao ZhangAili WangTan XuYonghong ZhangJiang HePublished in: Neurology (2022)
Increased plasma thrombomodulin levels at baseline were associated with decreased risks of adverse clinical outcomes at 3 months after ischemic stroke, suggesting a protective role of thrombomodulin in the development of ischemic stroke. Further studies from various populations are needed to replicate our findings.